Vivos Therapeutics, Inc. Capital Expenditures Incurred but Not yet Paid
Vivos Therapeutics, Inc. (VVOS) reported Capital Expenditures Incurred but Not yet Paid of $110.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2023-03-30
- Vivos Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2021 was $110.00K, a 5400.00% increase from fiscal 2020.
- Vivos Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2020 was $2.00K, a 97.82% decline from fiscal 2019.
- Vivos Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2019 was $91.72K.
| Period end | Capital Expenditures Incurred but Not yet Paid 12 month | Capital Expenditures Incurred but Not yet Paid 12 month as first filed |
|---|---|---|
| 2021-12-31 | $110.00K 10-K · filed 2023-03-30 | |
| 2020-12-31 | $2.00K 10-K · filed 2022-03-31 | $2.40K 10-K · filed 2021-03-25 |
| 2019-12-31 | $91.72K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |